Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 13 de 13
Filter
Add more filters










Publication year range
1.
J Clin Microbiol ; 56(9)2018 09.
Article in English | MEDLINE | ID: mdl-29899004

ABSTRACT

A rectal culture-guided antimicrobial prophylaxis strategy may prevent infections after transrectal ultrasound-guided prostate biopsy (TRUSP). The use of selective culture media could assist the choice of appropriate antibiotic prophylaxis. The objective of our study was to evaluate the performance of four selective media used for guidance of oral antibiotic prophylaxis in TRUSP. In this prospective validation study, we used MacConkey media with vancomycin plus one of the following antibiotics: ciprofloxacin (McC3+CIP/V), trimethoprim (McC3+TMP/V), fosfomycin (McC3+FOF/V), and amdinocillin-amoxicillin-clavulanic acid (McC3+MEC/V). First, clinical strains of Gram-negative bacilli (GNB) (n = 33) were evaluated for growth on the selective media. Thereafter, rectal swabs (n = 97) were randomly collected from residual material of fresh stool samples and plated on a growth control and the four selective media. Levels of recovery of GNB on the growth control and selective media were compared, and the MICs of the antibiotics used in this study were determined. The sensitivity and specificity of the four selective media amounted, respectively, to 90.0% (55.5 to 99.8%) and 98.7% (93.1 to 100.0%) for McC3+CIP/V, 95.7% (85.2 to 99.5%) and 100.0% (91.6 to 100.0%) for McC3+TMP/V, 95.5% (84.5 to 99.4%) and 97.8% (88.2 to 99.9%) for McC3+FOF/V, and 100.0% (76.8 to 100.0%) and 97.6% (87.4 to 99.9%) for McC3+MEC/V. In conclusion, the four selective media were sufficiently sensitive and specific for the identification of rectal GNB resistant to ciprofloxacin, trimethoprim, fosfomycin, or amdinocillin-amoxicillin-clavulanic acid. These media can have added value in streamlining the optimal culture based antibiotic prophylaxis in TRUSP in a non-labor-intensive manner.


Subject(s)
Anti-Bacterial Agents/pharmacology , Antibiotic Prophylaxis/methods , Drug Resistance, Bacterial , Gram-Negative Bacteria/drug effects , Microbial Sensitivity Tests , Postoperative Complications/prevention & control , Prostate/pathology , Anti-Bacterial Agents/chemistry , Clinical Decision-Making , Culture Media/chemistry , Feces/microbiology , Gram-Negative Bacteria/isolation & purification , Humans , Image-Guided Biopsy , Male , Postoperative Complications/drug therapy , Postoperative Complications/microbiology , Prospective Studies , Prostate/diagnostic imaging , Rectum/microbiology , Sensitivity and Specificity
2.
Theranostics ; 7(5): 1277-1289, 2017.
Article in English | MEDLINE | ID: mdl-28435465

ABSTRACT

Cardiovascular risk factors, especially hypertension, are also major risk factors for Alzheimer's disease (AD). To elucidate the underlying vascular origin of neurodegenerative processes in AD, we investigated the relation between systolic blood pressure (SBP) cerebral blood flow (CBF) and vasoreactivity with brain structure and function in a 16-18 months old double transgenic AßPPswe/PS1dE9 (AßPP/PS1) mouse model for AD. These aging AßPP/PS1 mice showed an increased SBP linked to a declined regional CBF. Furthermore, using advanced MRI techniques, decline of functional and structural connectivity was revealed in the AD-like mice coupled to impaired cognition, increased locomotor activity, and anxiety-related behavior. Post mortem analyses demonstrated also increased neuroinflammation, and both decreased synaptogenesis and neurogenesis in the AßPP/PS1 mice. Additionally, deviant levels of fatty acids and sterols were present in the brain tissue of the AßPP/PS1 mice indicating maladapted brain fatty acid metabolism. Our findings suggest a link between increased SBP, decreased cerebral hemodynamics and connectivity in an AD mouse model during aging, leading to behavioral and cognitive impairments. As these results mirror the complex clinical symptomatology in the prodromal phase of AD, we suggest that this AD-like murine model could be used to investigate prevention and treatment strategies for early AD patients. Moreover, this study helps to develop more efficient therapies and diagnostics for this very early stage of AD.


Subject(s)
Aging/pathology , Alzheimer Disease/physiopathology , Amyloid beta-Peptides/genetics , Cerebrovascular Disorders/complications , Cognitive Dysfunction/physiopathology , Hypertension/complications , Presenilin-1/genetics , Animals , Cerebrovascular Disorders/pathology , Disease Models, Animal , Hypertension/pathology , Magnetic Resonance Imaging , Mice , Mice, Inbred C57BL , Mice, Transgenic
3.
PLoS One ; 11(5): e0155307, 2016.
Article in English | MEDLINE | ID: mdl-27171180

ABSTRACT

Apolipoprotein E4 (ApoE4), one of three common isoforms of ApoE, is a major risk factor for late-onset Alzheimer disease (AD). ApoE-deficient mice, as well as mice expressing human ApoE4, display impaired learning and memory functions and signs of neurodegeneration. Moreover, ApoE protects against high-fat (HF) diet induced neurodegeneration by its role in the maintenance of the integrity of the blood-brain barrier. The influence of a HF diet on the progression of AD-like cognitive and neuropathological changes was assessed in wild-type (WT), human ApoE4 and ApoE-knockout (ApoE-/-) mice to evaluate the modulatory role of ApoE in this process. From 12 months of age, female WT, ApoE4, and ApoE-/- mice were fed either a standard or a HF diet (19% butter, 0.5% cholate, 1.25% cholesterol) throughout life. At 15 months of age mice performed the Morris water maze, evaluating spatial learning and memory. ApoE-/- showed increased spatial learning compared to WT mice (p = 0.009). HF diet improved spatial learning in WT mice (p = 0.045), but did not affect ApoE4 and ApoE-/- mice. Immunohistochemical analyses of the hippocampus demonstrated increased neuroinflammation (CD68) in the cornu ammonis 1 (CA1) region in ApoE4 (p = 0.001) and in ApoE-/- (p = 0.032) mice on standard diet. HF diet tended to increase CD68 in the CA1 in WT mice (p = 0.052), while it decreased in ApoE4 (p = 0.009), but ApoE-/- remained unaffected. A trend towards increased neurogenesis (DCX) was found in both ApoE4 (p = 0.052) and ApoE-/- mice (p = 0.068). In conclusion, these data suggest that HF intake induces different effects in WT mice compared to ApoE4 and ApoE-/- with respect to markers for cognition and neurodegeneration. We propose that HF intake inhibits the compensatory mechanisms of neuroinflammation and neurogenesis in aged female ApoE4 and ApoE-/- mice.


Subject(s)
Apolipoprotein E4/deficiency , Brain/pathology , Brain/physiopathology , Cognition/physiology , Inflammation/pathology , Neuronal Plasticity , Animals , Antigens, CD/metabolism , Antigens, Differentiation, Myelomonocytic/metabolism , Apolipoprotein E4/metabolism , Body Weight , Dentate Gyrus/metabolism , Diet, High-Fat , Disks Large Homolog 4 Protein , Doublecortin Domain Proteins , Doublecortin Protein , Female , Gene Knock-In Techniques , Glucose Transporter Type 1/metabolism , Guanylate Kinases/metabolism , Humans , Immunohistochemistry , Maze Learning , Membrane Proteins/metabolism , Mice, Knockout , Microtubule-Associated Proteins/metabolism , Neuropeptides/metabolism , Organ Size
4.
Neural Plast ; 2016: 6846721, 2016.
Article in English | MEDLINE | ID: mdl-27034849

ABSTRACT

APOE ε4 (apoE4) polymorphism is the main genetic determinant of sporadic Alzheimer's disease (AD). A dietary approach (Fortasyn) including docosahexaenoic acid, eicosapentaenoic acid, uridine, choline, phospholipids, folic acid, vitamins B12, B6, C, and E, and selenium has been proposed for dietary management of AD. We hypothesize that the diet could inhibit AD-like pathologies in apoE4 mice, specifically cerebrovascular and connectivity impairment. Moreover, we evaluated the diet effect on cerebral blood flow (CBF), functional connectivity (FC), gray/white matter integrity, and postsynaptic density in aging apoE4 mice. At 10-12 months, apoE4 mice did not display prominent pathological differences compared to wild-type (WT) mice. However, 16-18-month-old apoE4 mice revealed reduced CBF and accelerated synaptic loss. The diet increased cortical CBF and amount of synapses and improved white matter integrity and FC in both aging apoE4 and WT mice. We demonstrated that protective mechanisms on vascular and synapse health are enhanced by Fortasyn, independent of apoE genotype. We further showed the efficacy of a multimodal translational approach, including advanced MR neuroimaging, to study dietary intervention on brain structure and function in aging.


Subject(s)
Aging , Alzheimer Disease/diet therapy , Alzheimer Disease/physiopathology , Brain/blood supply , Brain/physiopathology , Alzheimer Disease/genetics , Animals , Apolipoprotein E4/genetics , Apolipoproteins E/genetics , Brain/metabolism , Brain Mapping , Diet , Disks Large Homolog 4 Protein , Fatty Acids/metabolism , Female , Guanylate Kinases/metabolism , Magnetic Resonance Imaging , Male , Membrane Proteins/metabolism , Mice , Mice, Inbred C57BL , Mice, Transgenic , Neural Pathways/blood supply , Neural Pathways/metabolism , Neural Pathways/physiopathology , Sterols/blood
5.
J Neurosci ; 34(42): 13963-75, 2014 Oct 15.
Article in English | MEDLINE | ID: mdl-25319693

ABSTRACT

It is well established that the cholesterol-transporter apolipoprotein ε (APOE) genotype is associated with the risk of developing neurodegenerative diseases. Recently, brain functional connectivity (FC) in apoE-ε4 carriers has been investigated by means of resting-state fMRI, showing a marked differentiation in several functional networks at different ages compared with carriers of other apoE isoforms. The causes of such hampered FC are not understood. We hypothesize that vascular function and synaptic repair processes, which are both impaired in carriers of ε4, are the major contributors to the loss of FC during aging. To test this hypothesis, we integrated several different MRI techniques with immunohistochemistry and investigated FC changes in relation with perfusion, diffusion, and synaptic density in apoE4 and apoE-knock-out (KO) mice at 12 (adult) and 18 months of age. Compared with wild-type mice, we detected FC deficits in both adult and old apoE4 and apoE-KO mice. In apoE4 mice, these changes occurred concomitant with increased mean diffusivity in the hippocampus, whereas perfusion deficits appear only later in life, together with reduced postsynaptic density levels. Instead, in apoE-KO mice FC deficits were mirrored by strongly reduced brain perfusion since adulthood. In conclusion, we provide new evidence for a relation between apoE and brain connectivity, possibly mediated by vascular risk factors and by the efficiency of APOE as synaptic modulator in the brain. Our results show that multimodal MR neuroimaging is an excellent tool to assess brain function and to investigate early neuropathology and aging effects in translational research.


Subject(s)
Aging/metabolism , Apolipoprotein E4/deficiency , Brain/metabolism , Nerve Net/metabolism , Rest/physiology , Aging/pathology , Animals , Apolipoproteins E/deficiency , Brain/pathology , Cells, Cultured , Female , Humans , Male , Mice , Mice, 129 Strain , Mice, Inbred C57BL , Mice, Knockout , Mice, Transgenic , Nerve Net/pathology
6.
Neurobiol Aging ; 35(3): 600-13, 2014 Mar.
Article in English | MEDLINE | ID: mdl-24210253

ABSTRACT

Nutritional intervention may retard the development of Alzheimer's disease (AD). In this study we tested the effects of 2 multi-nutrient diets in an AD mouse model (APPswe/PS1dE9). One diet contained membrane precursors such as omega-3 fatty acids and uridine monophosphate (DEU), whereas another diet contained cofactors for membrane synthesis as well (Fortasyn); the diets were developed to enhance synaptic membranes synthesis, and contain components that may improve vascular health. We measured cerebral blood flow (CBF) and water diffusivity with ultra-high-field magnetic resonance imaging, as alterations in these parameters correlate with clinical symptoms of the disease. APPswe/PS1dE9 mice on control diet showed decreased CBF and changes in brain water diffusion, in accordance with findings of hypoperfusion, axonal disconnection and neuronal loss in patients with AD. Both multinutrient diets were able to increase cortical CBF in APPswe/PS1dE9 mice and Fortasyn reduced water diffusivity, particularly in the dentate gyrus and in cortical regions. We suggest that a specific diet intervention has the potential to slow AD progression, by simultaneously improving cerebrovascular health and enhancing neuroprotective mechanisms.


Subject(s)
Alzheimer Disease/diet therapy , Alzheimer Disease/physiopathology , Brain/blood supply , Cerebrovascular Circulation , Fatty Acids, Omega-3/administration & dosage , Uridine Monophosphate/administration & dosage , Alzheimer Disease/genetics , Alzheimer Disease/prevention & control , Amyloid beta-Protein Precursor/genetics , Animals , Body Water/metabolism , Brain/metabolism , Brain/pathology , Diffusion Tensor Imaging , Disease Models, Animal , Disease Progression , Fatty Acids, Omega-3/pharmacology , Male , Mice , Mice, Transgenic , Neuroprotective Agents , Presenilin-1/genetics , Uridine Monophosphate/pharmacology
7.
Brain Struct Funct ; 219(5): 1841-68, 2014 Sep.
Article in English | MEDLINE | ID: mdl-23832599

ABSTRACT

Lipid metabolism and genetic background together strongly influence the development of both cardiovascular and neurodegenerative diseases like Alzheimer's disease (AD). A non-pharmacological way to prevent the genotype-induced occurrence of these pathologies is given by dietary behavior. In the present study, we tested the effects of long-term consumption of a specific multi-nutrient diet in two models for atherosclerosis and vascular risk factors in AD: the apolipoprotein ε4 (apoE4) and the apoE knockout (apoE ko) mice. This specific multi-nutrient diet was developed to support neuronal membrane synthesis and was expected to contribute to the maintenance of vascular health. At 12 months of age, both genotypes showed behavioral changes compared to control mice and we found increased neurogenesis in apoE ko mice. The specific multi-nutrient diet decreased anxiety-related behavior in the open field, influenced sterol composition in serum and brain tissue, and increased the concentration of omega-3 fatty acids in the brain. Furthermore, we found that wild-type and apoE ko mice fed with this multi-nutrient diet showed locally increased cerebral blood volume and decreased hippocampal glutamate levels. Taken together, these data suggest that a specific dietary intervention has beneficial effects on early pathological consequences of hypercholesterolemia and vascular risk factors for AD.


Subject(s)
Alzheimer Disease/diet therapy , Apolipoprotein E4/deficiency , Apolipoprotein E4/genetics , Brain/metabolism , Cognition Disorders/prevention & control , Diet , Hemodynamics/genetics , Alzheimer Disease/complications , Alzheimer Disease/genetics , Amyloid beta-Protein Precursor/genetics , Animals , Brain/drug effects , Cognition Disorders/etiology , Cognition Disorders/genetics , Cognition Disorders/pathology , Disease Models, Animal , Exploratory Behavior , Hemodynamics/drug effects , Humans , Male , Maze Learning , Mice , Mice, Inbred C57BL , Mice, Transgenic , Mutation/genetics , Neurogenesis , Organ Size , Presenilin-1/genetics
8.
PLoS One ; 8(9): e75393, 2013.
Article in English | MEDLINE | ID: mdl-24086523

ABSTRACT

Recent studies have focused on the use of multi-nutrient dietary interventions in search of alternatives for the treatment and prevention of Alzheimer's disease (AD). In this study we investigated to which extent long-term consumption of two specific multi-nutrient diets can modulate AD-related etiopathogenic mechanisms and behavior in 11-12-month-old AßPPswe-PS1dE9 mice. Starting from 2 months of age, male AßPP-PS1 mice and wild-type littermates were fed either a control diet, the DHA+EPA+UMP (DEU) diet enriched with uridine monophosphate (UMP) and the omega-3 fatty acids docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA), or the Fortasyn® Connect (FC) diet enriched with the DEU diet plus phospholipids, choline, folic acid, vitamins and antioxidants. We performed behavioral testing, proton magnetic resonance spectroscopy, immunohistochemistry, biochemical analyses and quantitative real-time PCR to gain a better understanding of the potential mechanisms by which these multi-nutrient diets exert protective properties against AD. Our results show that both diets were equally effective in changing brain fatty acid and cholesterol profiles. However, the diets differentially affected AD-related pathologies and behavioral measures, suggesting that the effectiveness of specific nutrients may depend on the dietary context in which they are provided. The FC diet was more effective than the DEU diet in counteracting neurodegenerative aspects of AD and enhancing processes involved in neuronal maintenance and repair. Both diets elevated interleukin-1ß mRNA levels in AßPP-PS1 and wild-type mice. The FC diet additionally restored neurogenesis in AßPP-PS1 mice, decreased hippocampal levels of unbound choline-containing compounds in wild-type and AßPP-PS1 animals, suggesting diminished membrane turnover, and decreased anxiety-related behavior in the open field behavior. In conclusion, the current data indicate that specific multi-nutrient diets can influence AD-related etiopathogenic processes. Intervention with the FC diet might be of interest for several other neurodegenerative and neurological disorders.


Subject(s)
Alzheimer Disease/diet therapy , Alzheimer Disease/prevention & control , Brain/metabolism , Cognition/physiology , Food, Fortified/analysis , Analysis of Variance , Animals , Brain/drug effects , Cholesterol/blood , Cognition/drug effects , DNA Primers/genetics , Docosahexaenoic Acids , Eicosapentaenoic Acid , Fatty Acids/metabolism , Immunohistochemistry , Interleukin-1beta/metabolism , Magnetic Resonance Spectroscopy , Male , Maze Learning/drug effects , Mice , Mice, Mutant Strains , Real-Time Polymerase Chain Reaction , Uridine Monophosphate
9.
J Alzheimers Dis ; 37(1): 233-45, 2013.
Article in English | MEDLINE | ID: mdl-23803297

ABSTRACT

There is accumulating evidence showing that lifestyle factors like diet may influence the onset and progression of Alzheimer's disease (AD). Our previous studies suggest that a multi-nutrient diet, Fortasyn, containing nutritional precursors and cofactors for membrane synthesis, viz. docosahexaenoic acid, eicosapentaenoic acid, uridine-mono-phosphate, choline, phospholipids, folic acid, vitamins B6, B12, C, E, and selenium, has an ameliorating effect on cognitive deficits in an AD mouse model. In the present study we analyzed learning strategies and memory of 11-month-old AßPPswe/PS1dE9 (AßPP/PS1) mice in the Morris water maze (MWM) task performed after nine months of dietary intervention with a control diet or a Fortasyn diet to characterize diet-induced changes in cognitive performance. The Fortasyn diet had no significant effect on MWM task acquisition. To assess hippocampus-dependent learning, the strategies that the mice used to find the hidden platform in the MWM were analyzed using the swim path data. During the fourth day of the MWM, AßPP/PS1 mice on control diet more often used the non-spatial random search strategy, while on the Fortasyn diet, the transgenic animals exhibited more chaining strategy than their wild-type littermates. During the probe trial, AßPP/PS1 mice displayed no clear preference for the target quadrant. Notably, in both transgenic and nontransgenic mice on Fortasyn diet, the latency to reach the former platform position was decreased compared to mice on the control diet. In conclusion, this specific nutrient combination showed a tendency to improve searching behavior in AßPP/PS1 mice by increasing the use of a more efficient search strategy and improving their swim efficiency by decreasing the latency to reach the former platform position.


Subject(s)
Aging/metabolism , Alzheimer Disease/diet therapy , Diet/methods , Maze Learning/physiology , Memory/physiology , Spatial Behavior/physiology , Aging/psychology , Alzheimer Disease/genetics , Alzheimer Disease/psychology , Amyloid beta-Protein Precursor/genetics , Animals , Male , Mice , Mice, Inbred C3H , Mice, Inbred C57BL , Mice, Transgenic , Presenilin-1/genetics
10.
PLoS One ; 8(5): e63643, 2013.
Article in English | MEDLINE | ID: mdl-23717459

ABSTRACT

Proton magnetic resonance spectroscopy ((1)H MRS) is a valuable tool in Alzheimer's disease research, investigating the functional integrity of the brain. The present longitudinal study set out to characterize the neurochemical profile of the hippocampus, measured by single voxel (1)H MRS at 7 Tesla, in the brains of AßPPSswe-PS1dE9 and wild-type mice at 8 and 12 months of age. Furthermore, we wanted to determine whether alterations in hippocampal metabolite levels coincided with behavioral changes, cognitive decline and neuropathological features, to gain a better understanding of the underlying neurodegenerative processes. Moreover, correlation analyses were performed in the 12-month-old AßPP-PS1 animals with the hippocampal amyloid-ß deposition, TBS-T soluble Aß levels and high-molecular weight Aß aggregate levels to gain a better understanding of the possible involvement of Aß in neurochemical and behavioral changes, cognitive decline and neuropathological features in AßPP-PS1 transgenic mice. Our results show that at 8 months of age AßPPswe-PS1dE9 mice display behavioral and cognitive changes compared to age-matched wild-type mice, as determined in the open field and the (reverse) Morris water maze. However, there were no variations in hippocampal metabolite levels at this age. AßPP-PS1 mice at 12 months of age display more severe behavioral and cognitive impairment, which coincided with alterations in hippocampal metabolite levels that suggest reduced neuronal integrity. Furthermore, correlation analyses suggest a possible role of Aß in inflammatory processes, synaptic dysfunction and impaired neurogenesis.


Subject(s)
Amyloid beta-Protein Precursor/metabolism , Cognition/physiology , Hippocampus/pathology , Neurons/pathology , Synapses/pathology , Aging , Alzheimer Disease/metabolism , Alzheimer Disease/pathology , Amyloid beta-Peptides/metabolism , Animals , Cognition Disorders/metabolism , Cognition Disorders/pathology , Disease Models, Animal , Hippocampus/metabolism , Longitudinal Studies , Magnetic Resonance Spectroscopy/methods , Male , Maze Learning/physiology , Mice , Mice, Inbred C3H , Mice, Inbred C57BL , Mice, Transgenic , Neurons/metabolism , Synapses/metabolism
11.
Neurobiol Aging ; 34(5): 1440-50, 2013 May.
Article in English | MEDLINE | ID: mdl-23273575

ABSTRACT

In patients with Alzheimer's disease (AD) the severity of white matter degeneration correlates with the clinical symptoms of the disease. In this study, we performed diffusion-tensor magnetic resonance imaging at ultra-high field in a mouse model for AD (APP(swe)/PS1(dE9)) in combination with a voxel-based approach and tractography to detect changes in water diffusivity in white and gray matter, because these reflect structural alterations in neural tissue. We found substantial changes in water diffusion parallel and perpendicular to axonal tracts in several white matter regions like corpus callosum and fimbria of the hippocampus, that match with previous findings of axonal disconnection and myelin degradation in AD patients. Moreover, we found a significant increase in diffusivity in specific hippocampal subregions, which is supported by neuronal loss as visualized with Klüver-Barrera staining. This work demonstrates the potential of ultra-high field diffusion-tensor magnetic resonance imaging as a noninvasive modality to describe white and gray matter structural changes in mouse models for neurodegenerative disorders, and provides valuable knowledge to assess future AD prevention strategies in translational research.


Subject(s)
Alzheimer Disease/pathology , Disease Models, Animal , Hippocampus/pathology , Nerve Fibers, Myelinated/pathology , Neurons/pathology , Animals , Humans , Mice , Mice, Transgenic
12.
Brain Struct Funct ; 218(5): 1085-98, 2013 Sep.
Article in English | MEDLINE | ID: mdl-22892904

ABSTRACT

Vascular disorders can either be cause or consequence in the pathophysiology of Alzheimer's disease (AD). To comprehensively characterize the occurrence of vascular impairment in a double transgenic mouse model for AD (APPswe/PS1dE9) during aging, we developed a new method to obtain microvascular relative cerebral blood volume (rCBV(micro)) maps from gradient echo MR imaging by histogram evaluation and we applied a voxel-wise approach to detect rCBV(micro) changes. With this methodology the development of cerebral microvascular impairments can be described in vivo with 0.16 mm isotropic resolution for the whole mouse brain. At 8 months, impaired rCBV(micro) appeared in some cortical regions and in the thalamus, which spreads over several sub-cortical areas and the hippocampus at 13 months. With a ROI-based approach, we further showed that hippocampal rCBV(micro) in 13-month-old wild-type and APP(swe)/PS1(dE9) mice correlates well with capillary density measured with immunohistochemical staining. However, no differences in capillary density were detected between genotypes. The rCBV(micro) values showed no significant correlation with amyloid-ß (Aß) plaque deposition, Aß at blood vessel walls and biochemically measured levels of Aß1₋40, Aß1₋42 oligomers and fibrillar forms. These results suggest that rCBV(micro) reduction is caused by an impaired vasoactivity of capillaries and arterioles, which is not directly correlated with the amount of Aß deposition in parenchyma nor blood vessel walls.


Subject(s)
Aging/physiology , Alzheimer Disease/complications , Cerebrum/blood supply , Microvessels/physiopathology , Models, Animal , Vascular Diseases/complications , Amyloid beta-Peptides/metabolism , Amyloid beta-Protein Precursor/genetics , Analysis of Variance , Animals , Blood Volume Determination , Glucose Transporter Type 1/metabolism , Immunohistochemistry , Magnetic Resonance Imaging/methods , Mice , Mice, Transgenic , Presenilin-1/genetics
13.
J Alzheimers Dis ; 31(4): 813-26, 2012.
Article in English | MEDLINE | ID: mdl-22717611

ABSTRACT

Research into the development of Alzheimer's disease (AD) provides increasing evidence that vascular risk factors, including high serum cholesterol, might influence the progression of cognitive impairment and neural degeneration. In this study, we investigated the effects of high dietary cholesterol intake and the cholesterol-lowering liver X receptor-agonist T0901317 on capillary density, amyloid-ß deposition, and presynaptic boutons in the hippocampus of adult (8 months) and aged (15 months) AßPPswe-PS1dE9 and wild-type mice to elucidate how cholesterol may affect neurodegenerative processes in aging and AD. Our results show increased number of presynaptic boutons in 15-month-old AßPP-PS1 mice compared to age-matched wild-type animals, but no difference at 8 months of age. High cholesterol intake accelerated this response by increasing the amount of presynaptic boutons at 8 and 15 months of age, while T0901317 intake decreased the amount of presynaptic boutons in 15-month-old AßPP-PS1 mice. These findings suggest a synaptic compensatory response to maintain connectivity during aging. We hypothesize that high cholesterol intake may cause impaired cerebral blood flow inducing ischemia, fortifying the above mentioned hypothesis of a compensatory mechanism. Contrarily, cholesterol-lowering agents may positively influence cerebral circulation, thereby diminishing aggravation of AD-like pathology.


Subject(s)
Aging/metabolism , Alzheimer Disease/metabolism , Brain/metabolism , Cholesterol, Dietary/administration & dosage , Synapses/metabolism , Aging/drug effects , Alzheimer Disease/pathology , Alzheimer Disease/prevention & control , Animals , Anticholesteremic Agents/pharmacology , Anticholesteremic Agents/therapeutic use , Brain/drug effects , Male , Mice , Mice, Inbred C3H , Mice, Inbred C57BL , Mice, Transgenic , Synapses/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL
...